LOG IN
SIGN UP
MARKET
EXPO
EXPO
Exponent Inc
NASDAQ
Real-time Quotes | Nasdaq Last Sale
90.86
+1.16
+1.29%
Opening 14:56 05/27 EDT
OPEN
90.00
PREV CLOSE
89.70
HIGH
91.64
LOW
90.00
VOLUME
82.43K
TURNOVER
4.83M
52 WEEK HIGH
127.61
52 WEEK LOW
83.49
MARKET CAP
4.71B
P/E (TTM)
48.39
1D
5D
1M
3M
1Y
5Y
Exponent to Present at Upcoming Investor Conferences
MENLO PARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present ...
GlobeNewswire · 4d ago
After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for Exponent (EXPO)
The heavy selling pressure might have exhausted for Exponent (EXPO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the ...
Zacks · 05/19 13:35
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 19.9% in 4 Weeks
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend r...
Zacks · 05/12 13:35
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 16.5% in 4 Weeks
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend r...
Zacks · 05/09 13:35
Declining Stock and Solid Fundamentals: Is The Market Wrong About Exponent, Inc. (NASDAQ:EXPO)?
Exponent (NASDAQ:EXPO) has had a rough month with its share price down 16%. However, a closer look at its sound...
Simply Wall St. · 05/06 19:20
Here's Why Exponent (EXPO) is Poised for a Turnaround After Losing 14.6% in 4 Weeks
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend r...
Zacks · 05/04 13:35
Exponent (EXPO) Q1 Earnings and Revenues Beat Estimates
Exponent (EXPO) delivered earnings and revenue surprises of 7.69% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/28 21:15
BRIEF-Exponent Reports First Quarter 2022 Financial Results
reuters.com · 04/28 20:51
No Data
Learn about the latest financial forecast of EXPO. Analyze the recent business situations of Exponent Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 3 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
0.00%Strong Buy
66.67%Buy
33.33%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average EXPO stock price target is 118.00 with a high estimate of 120.00 and a low estimate of 116.00.
Current 90.86
EPS
Actual
Estimate
0.140.280.420.56
Institutional Holdings
Institutions: 489
Institutional Holdings: 49.63M
% Owned: 95.76%
Shares Outstanding: 51.82M
TypeInstitutionsShares
Increased
138
2.93M
New
38
169.65K
Decreased
111
1.97M
Sold Out
40
892.29K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Business Support Services
+2.91%
Professional & Commercial Services
+2.29%
Key Executives
Chairman/Director
Paul Johnston
President/Chief Executive Officer/Director
Catherine Corrigan
Chief Financial Officer/Executive Vice President/Secretary
Richard Schlenker
Chief Human Resource Officer
Sally Shepard
Vice President
John Doyle
Vice President
Brad James
Vice President
Harri Kytomaa
Vice President
Steven Murray
Vice President
John Pye
Vice President
Richard Reiss
Vice President
Maureen Reitman
Lead Director/Independent Director
John Shoven
Independent Director
George Brown
Independent Director
Carol Lindstrom
Independent Director
Karen Richardson
Independent Director
Debra Zumwalt
No Data
No Data
About EXPO
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting company. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property and impending litigation.
Webull offers kinds of Exponent, Inc. stock information, including NASDAQ:EXPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EXPO stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading EXPO stock methods without spending real money on the virtual paper trading platform.